Common TitleMINMON (ACTGA5360)
Official Title A Single-arm Study to Evaluate the Feasibility and Efficacy of a Minimal Monitoring Strategy to Deliver Pan-genotypic Ribavirin-free HCV Therapy to HCV Infected Populations Who Are HCV Treatment Naïve With Evidence of Active HCV Infection: The MINMON Study
Phase Phase IV
ClinicalTrials.gov NCT03512210
Treatments
Sofosbuvir-Velpatasvir

Sofosbuvir-Velpatasvir
Tradename:EpclusaOther Names:SOF-VELClass:FDA-ApprovedFunding
IndustryGilead Sciences
Non-IndustryUS National Institutes of Health